Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fort Myers, FL
NPI
1346241254
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
8380 Riverwalk Park Blvd Ste 200
Fort Myers, FL, 33919
Phone (239) 600-7808
Groups this clinician bills Medicare through
Medicare paid, 2024
$351K
6,826 services
Medicare patients, 2024
1,028
Average age 74
Drug cost, 2024
$1.7M
4,243 prescriptions
Company payments, 2025
$272
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Athanassios Drimoussis was code 99214 (office e&m - established), 3,096 times for 992 patients. In total Athanassios Drimoussis billed 6,826 services in 34 codes, and Medicare paid $351K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,096 | 992 | $91.22 | $282K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,936 | 761 | $12.62 | $24K |
| 36415 Venipuncture Blood Collection | Office | 384 | 262 | $8.63 | $3,313 |
| 95251 Test - Miscellaneous | Office | 168 | 73 | $26.08 | $4,382 |
| 99204 Office E&M - New | Office | 165 | 165 | $119.29 | $20K |
| 80053 Clinical Chemistry | Office | 160 | 117 | $10.35 | $1,656 |
| 84443 Clinical Chemistry | Office | 131 | 95 | $16.46 | $2,156 |
| 84439 Clinical Chemistry | Office | 130 | 94 | $8.84 | $1,149 |
| 80061 Clinical Chemistry | Office | 110 | 80 | $13.12 | $1,443 |
| 84481 Clinical Chemistry | Office | 98 | 74 | $16.60 | $1,627 |
| 83036 Blood Count | Office | 98 | 67 | $9.52 | $933 |
| 82043 Clinical Chemistry | Office | 78 | 55 | $5.66 | $441 |
| 82570 Clinical Chemistry | Office | 78 | 55 | $5.08 | $396 |
| 82306 Clinical Chemistry | Office | 31 | 28 | $29.01 | $899 |
| 99215 Office E&M - Established | Office | 23 | 23 | $124.64 | $2,867 |
By year: 2022 $423K for 12,825 services; 2023 $367K for 7,622 services; 2024 $351K for 6,826 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 384 | 262 | $8.63 | $3,313 |
| 80053 Clinical Chemistry | 160 | 117 | $10.35 | $1,656 |
| 84443 Clinical Chemistry | 131 | 95 | $16.46 | $2,156 |
| 84439 Clinical Chemistry | 130 | 94 | $8.84 | $1,149 |
| 80061 Clinical Chemistry | 110 | 80 | $13.12 | $1,443 |
| 84481 Clinical Chemistry | 98 | 74 | $16.60 | $1,627 |
| 83036 Blood Count | 98 | 67 | $9.52 | $933 |
| 82570 Clinical Chemistry | 78 | 55 | $5.08 | $396 |
| 82043 Clinical Chemistry | 78 | 55 | $5.66 | $441 |
| 82306 Clinical Chemistry | 31 | 28 | $29.01 | $899 |
Medicare prescription drug claims, 2024
In 2024, the drug Athanassios Drimoussis prescribed most often to Medicare patients was Levothyroxine Sodium, with 734 prescriptions and refills. In total Athanassios Drimoussis wrote 4,243 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 734 | 2,148 | 262 | $5,673 |
| Rosuvastatin Calcium Generic | 265 | 774 | 105 | $4,377 |
| Metformin Hcl Generic | 235 | 680 | 112 | $1,784 |
| Januvia Sitagliptin Phosphate | 177 | 415 | 72 | $222K |
| Janumet Sitagliptin Phos/Metformin Hcl | 173 | 426 | 65 | $228K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 168 | 438 | 71 | $18K |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 159 | 349 | 82 | $74K |
| Synthroid Levothyroxine Sodium | 137 | 380 | 51 | $13K |
| Jardiance Empagliflozin | 133 | 337 | 54 | $205K |
| Ozempic Semaglutide | 129 | 210 | 38 | $188K |
| Farxiga Dapagliflozin Propanediol | 128 | 299 | 60 | $166K |
| Atorvastatin Calcium Generic | 119 | 358 | 48 | $1,001 |
| Ezetimibe Generic | 95 | 281 | 41 | $2,209 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 95 | 214 | 45 | $40K |
| Methimazole Generic | 83 | 242 | 49 | $797 |
Brand drugs: 2,136 claims; generic drugs: 1,781 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Athanassios Drimoussis $272 ($272 in general payments such as food, travel and fees) from 6 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $82.09.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.